Ikechukwu Akunyili

Clinical trials

• Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer

  Principal investigator · Withdrawn · Phase 1

  Eckhard Podack

  2014
• Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

  Principal investigator · Completed

  University of Miami

  2009
• Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  Site PI · Recruiting · Phase 2, Phase 3

  SWOG Cancer Research Network

  2025–2028
• Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

  Site PI · Recruiting · Phase 2

  SWOG Cancer Research Network

  2024–2028